SCHEMBL312264

SCHEMBL312264

N#Cc1ccc(O)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30457749 1.00
SCHEMBL7285319 0.83 MMP3 (0.52)
SCHEMBL941512 0.76
SCHEMBL7921009 0.76
SCHEMBL14473398 0.76 ESR1 (0.53)
SCHEMBL12630708 0.73 CHEK1 (0.51)
SCHEMBL1026572 0.73 ALDH1A1 (0.48)
SCHEMBL156136 0.71
SCHEMBL42349 0.71
SCHEMBL1145963 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 344 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103012297-B Cyanate ester and polymer containing s-triazine structure and preparation methods of cyanate ester and polymer UNIV CENTRAL SOUTH 2015-05-06 CN claimed
CN-103012297-A Cyanate ester and polymer containing s-triazine structure and preparation methods of cyanate ester and polymer UNIV CENTRAL SOUTH 2013-04-03 CN claimed
EP-1702919-B1 NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE MSD KK (JP) 2012-05-30 EP claimed
EP-3704094-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-03-11 EP disclosed
EP-3604326-B1 PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND FUJIFILM CORP (JP) 2026-01-07 EP disclosed
US-20250388542-A1 ANALOGUES OF PENTAMIDINE AND USES THEREFOR AURANSA INC. (US) 2025-12-25 US disclosed
US-20250275959-A1 COMPOUNDS AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS, INC. 2025-09-04 US disclosed
US-20250276967-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES SIGNAL PHARMACEUTICALS, LLC 2025-09-04 US disclosed
US-12378218-B2 Cyclopentane compounds DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2025-08-05 US disclosed
US-12338235-B2 Heterocyclic compounds and their use for treatment of helminthic infections and diseases CELGENE CORPORATION (US) 2025-06-24 US disclosed
CN-116554145-B Aralkyl-4- (1H) indolylpiperazine derivative, preparation method and application thereof 江苏恩华药业股份有限公司 2025-06-03 CN disclosed
WO-2005030734-A1 DIAMINOPYRIMIDINE DERIVATIVES AS SELECTIVE GROWTH HORMONE SECRECTGOGUE RECEPTOR (GHS-R) ANTAGONISTS ABBOTT LABORATORIES (US) 2005-04-07 WO disclosed
WO-2005030785-A2 NOVEL THIOXYLOSE COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USE THEREOF IN THERAPEUTICS LABORATOIRES FOURNIER S.A. (FR) 2005-04-07 WO disclosed
US-20050070712-A1 Pyrimidine derivatives as ghrelin receptor modulators ABBOTT LABORATORIES 2005-03-31 US disclosed
EP-1047690-A1 HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION Abbott Laboratories (US) 2000-11-02 EP disclosed
WO-1999032480-A1 HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION ABBOTT LABORATORIES (US) 1999-07-01 WO disclosed
EP-0091464-B1 METHOD FOR THE PREPARATION OF CYANO-HETEROCYCLES SCHERING AKTIENGESELLSCHAFT (DE) 1986-04-16 EP disclosed
EP-0091464-A1 METHOD FOR THE PREPARATION OF CYANO-HETEROCYCLES. SCHERING AG (DE) 1983-10-19 EP disclosed
WO-1983001446-A1 METHOD FOR THE PREPARATION OF CYANO-HETEROCYCLES VORBRÜGGEN, Helmut 1983-04-28 WO disclosed
US-4046896-A 1-Methyl-2-(pyridyl-oxymethyl)-5-nitro-imidazoles HOECHST AKTIENGESELLSCHAFT (DT) 1977-09-06 US disclosed